Bajwa, R P S <br/><br/>
Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.  [electronic resource] 

 -  Bone marrow transplantation  Apr 2003 
 - 591-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703881  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bilirubin--blood<br/>Bone Marrow Transplantation--adverse effects<br/>Follow-Up Studies<br/>Hepatic Veno-Occlusive Disease--drug therapy<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Plasminogen Activators--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Risk Factors<br/>Severity of Illness Index<br/>Tissue Plasminogen Activator--administration & dosage<br/>Transplantation, Autologous